Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gilead slapped with US subpoena on manufacturing, distribution practices

This article was originally published in Scrip

Executive Summary

The market reacted only mildly to a subpoena Gilead Sciences received from the US Attorney's Office for the Northern District of California requesting documents related to the manufacture and related quality and distribution practices of several of the firm's drugs used to treat HIV/AIDS, pulmonary arterial hypertension and chronic hepatitis B.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC013283

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel